0001415889-24-001777.txt : 20240124 0001415889-24-001777.hdr.sgml : 20240124 20240124180032 ACCESSION NUMBER: 0001415889-24-001777 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240122 FILED AS OF DATE: 20240124 DATE AS OF CHANGE: 20240124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pigot Timothy CENTRAL INDEX KEY: 0001967140 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40544 FILM NUMBER: 24558063 MAIL ADDRESS: STREET 1: AEROVATE THERAPEUTICS, INC. STREET 2: 930 WINTER STREET, SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc. CENTRAL INDEX KEY: 0001798749 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831377888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 930 WINTER STREET STREET 2: SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-443-2400 MAIL ADDRESS: STREET 1: 930 WINTER STREET STREET 2: SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-01242024_060110.xml X0508 4 2024-01-22 0001798749 Aerovate Therapeutics, Inc. AVTE 0001967140 Pigot Timothy C/O AEROVATE THERAPEUTICS, INC. 930 WINTER STREET, SUITE M-500 WALTHAM MA 02451 false true false false CHIEF COMMERCIAL OFFICER 0 Common Stock 1291 D Stock Option (Right to Buy) 20 2024-01-22 4 A 0 66586 0 A 2034-01-21 Common Stock 66586 66586 D Includes 1,291 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2023 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d). This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on February 22, 2024. /s/ George A. Eldridge, Attorney-in-Fact 2024-01-24